ArticleMolecular therapy : the journal of the American Society of Gene Therapy2006

Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice.

Jennifer M Laing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.